Saeed Zaker Bostanabad, Karim Rahimi Mohammad, Parvaneh Adimi, Zahra Tayebee, Mozhgan Masoumi, Shahin Pourazar, Esmail Jabbarzadeh, Mehdi Shekarabi, Azarmidokht Pourmand, Konstantina Sourkova Larisa, Petrovich Titov Leonid
Department of Microbiology and Biology, Islamic Azad University, Parand Branch, Tehran, Iran; ; Department of Clinical Microbiology, Masoud Laboratory, Tehran, Iran;
Int J Biomed Sci. 2009 Dec;5(4):326-35.
This is the first genetic biodiversity study of Mycobacterium tuberculosis in Iran. Thus, we investigated the genetic patterns of strains isolated in the first survey of anti-tuberculosis drug-resistance by rpoB gene as part of the Global Project of Anti-tuberculosis Drug Resistance Surveillance (IAU, Iran). A 411-bp fragment of the rpoB gene, containing the sequence of the 81-bp rpoB fragment, was amplified by PCR and the rpoB gene fragments of tuberculosis strains were sequenced using the Amersham auto sequencer. For analysing tree evolution used method UPGMA and Neighbour-Joining. Clinical isolates (34/163) were analyzed by using sequencing gene rpoB and genotyped by program MEGA. The results were compared with the international database. Multi-drug resistant (MDR) was 14% in never treated patients and 8% in previously treated patients. Mutations in rpoB gene and katG genes were detected in 95% and 84% of the MDR strains, respectively. Two clusters were found to be identical by the four different analysis methods, presumably representing cases of recent transmission of MDR tuberculosis. The other strains are divided into 2 groups: group A - similar to the standard and Eastern strains (China, Taiwan) and group B - strains of another genotype. They are grouped separately on the dendrogram and became prevalent in Iran (they are called Iranian residential strains). This study gives a first overview of the M. tuberculosis strains circulating in Iran during the first survey of anti-tuberculosis drug-resistance. It may aid in the creation of a national database that will be a valuable support for further studies.
这是伊朗首次对结核分枝杆菌进行的遗传生物多样性研究。因此,作为全球抗结核药物耐药性监测项目(伊朗伊斯兰阿扎德大学)的一部分,我们通过rpoB基因调查了在首次抗结核药物耐药性调查中分离出的菌株的遗传模式。通过PCR扩增包含81bp rpoB片段序列的411bp rpoB基因片段,并使用Amersham自动测序仪对结核菌株的rpoB基因片段进行测序。使用UPGMA和邻接法分析树形进化。通过对rpoB基因进行测序分析临床分离株(34/163),并使用MEGA程序进行基因分型。将结果与国际数据库进行比较。从未接受过治疗的患者中耐多药(MDR)率为14%,既往接受过治疗的患者中为8%。分别在95%和84%的MDR菌株中检测到rpoB基因和katG基因的突变。通过四种不同的分析方法发现两个聚类是相同的,推测代表耐多药结核病近期传播的病例。其他菌株分为两组:A组——类似于标准菌株和东方菌株(中国、台湾),B组——另一种基因型的菌株。它们在树状图上分别分组,并在伊朗流行(它们被称为伊朗本地菌株)。这项研究首次概述了在首次抗结核药物耐药性调查期间在伊朗传播的结核分枝杆菌菌株。它可能有助于创建一个国家数据库,这将为进一步的研究提供宝贵的支持。